Literature DB >> 21054518

Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitis patients?

Jun Kato1, Motoaki Kuriyama, Sakiko Hiraoka, Kazuhide Yamamoto.   

Abstract

BACKGROUND AND AIMS: An adequate range of colonic observations for precise evaluation of inflammation in ulcerative colitis (UC) patients has not been reported.
METHODS: Retrospective analysis of 545 colonoscopic examinations of UC patients was carried out. Severity of mucosal inflammation was evaluated using the Mayo score of endoscopic index at each location (rectum, sigmoid colon, descending colon, and the oral side of the splenic flexure) in each patient. The colonic site with maximum inflammation was determined for each patient.
RESULTS: Of 545 patients, 319 (59%) had maximum inflammation in the rectum, 79 (14%) in the sigmoid colon, 70 (13%) in the descending colon, and 77 (14%) on the oral side of the splenic flexure. Severe inflammatory activity (Mayo 3) was observed more frequently in patients who had maximum activity in the descending colon or the more proximal portion than those who had this in the rectum or sigmoid colon (42% vs 25%, P<0.0001). The first-attack patients were significantly more frequently found in patients with maximum severity in the descending colon or the oral side of splenic flexure than those with maximum severity in the rectum or sigmoid colon (P=0.016). Moreover, among 134 patients with no inflammation in the rectum and sigmoid colon, 54 (40%) had inflamed mucosa in the descending colon or the more proximal portion.
CONCLUSIONS: Sigmoidoscopy is not sufficient for evaluating inflammation in UC patients. In particular, colonoscopy is necessary for first-attack patients and patients who have a discrepancy between rectosigmoid observation and symptoms.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21054518     DOI: 10.1111/j.1440-1746.2010.06562.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Noninvasive evaluation of mucosal healing in inflammatory bowel diseases.

Authors:  Jun Kato; Sakiko Hiraoka; Asuka Nakarai; Masao Ichinose
Journal:  Clin J Gastroenterol       Date:  2012-11-28

2.  How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.

Authors:  Anita Bálint; Klaudia Farkas; Zoltán Szepes; Ferenc Nagy; Mónika Szűcs; László Tiszlavicz; Renáta Bor; Ágnes Milassin; Mariann Rutka; Anna Fábián; Tamás Molnár
Journal:  BMC Gastroenterol       Date:  2018-01-08       Impact factor: 3.067

3.  Comparison of small-bowel colon capsule endoscopy system to conventional colonoscopy for the evaluation of ulcerative colitis activity.

Authors:  Samuel N Adler; Yago González Lama; Virginia Matallana Royo; Cristina Suárez Ferrer; Avraham Schwartz; Ariella Bar-Gil Shitrit
Journal:  Endosc Int Open       Date:  2019-10-01

4.  Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis.

Authors:  Su Bum Park; Seong-Jung Kim; Jun Lee; Yoo Jin Lee; Dong Hoon Baek; Geom Seog Seo; Eun Soo Kim; Sang-Wook Kim; So Yeong Kim
Journal:  BMC Gastroenterol       Date:  2022-02-27       Impact factor: 3.067

5.  Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis.

Authors:  Kousaku Kawashima; Shunji Ishihara; Takafumi Yuki; Nobuhiko Fukuba; Naoki Oshima; Hideaki Kazumori; Hiroki Sonoyama; Noritsugu Yamashita; Yasumasa Tada; Ryusaku Kusunoki; Akihiko Oka; Yoshiyuki Mishima; Ichiro Moriyama; Yoshikazu Kinoshita
Journal:  BMC Gastroenterol       Date:  2016-04-12       Impact factor: 3.067

6.  Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis.

Authors:  B Jharap; W J Sandborn; W Reinisch; G D'Haens; A M Robinson; W Wang; B Huang; A Lazar; R B Thakkar; J-F Colombel
Journal:  Aliment Pharmacol Ther       Date:  2015-09-03       Impact factor: 8.171

7.  Patient self-reported symptoms using visual analog scales are useful to estimate endoscopic activity in ulcerative colitis.

Authors:  Saya Tsuda; Reiko Kunisaki; Jun Kato; Mayu Murakami; Masafumi Nishio; Tsuyoshi Ogashiwa; Takeichi Yoshida; Hideaki Kimura; Masayuki Kitano
Journal:  Intest Res       Date:  2018-10-10

8.  Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitis.

Authors:  Mayu Uchihara; Jun Kato; Saya Tsuda; Takeichi Yoshida; Takao Maekita; Mikitaka Iguchi; Masayuki Kitano
Journal:  JGH Open       Date:  2017-11-01

Review 9.  Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments.

Authors:  Klaus Gottlieb; Marco Daperno; Keith Usiskin; Bruce E Sands; Harris Ahmad; Colin W Howden; William Karnes; Young S Oh; Irene Modesto; Colleen Marano; Ryan William Stidham; Walter Reinisch
Journal:  Gut       Date:  2020-07-22       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.